• Consensus Rating: N/A
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00%
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$6.80
▲ +0.1 (1.49%)

This chart shows the closing price for OROCF by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Allkem Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for OROCF and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for OROCF

Analyst Price Target is $0.00
▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for Allkem in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $6.80.

This chart shows the closing price for OROCF for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is N/A

The current consensus among 0 contributing investment analysts is to n/a stock in Allkem. This N/A consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
5/12/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
8/10/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
11/8/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
2/6/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
5/6/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
8/4/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/3/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
11/2/2024

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
6/23/2023HSBCDowngradeBuy ➝ Hold
4/21/2023Credit Suisse GroupUpgradeUnderperform ➝ Neutral
1/27/2023Jefferies Financial GroupDowngradeBuy ➝ Hold
1/10/2023Jefferies Financial GroupUpgradeHold ➝ Buy
12/8/2022Morgan StanleyDowngradeEqual Weight ➝ Underweight
12/7/2022The Goldman Sachs GroupInitiated CoverageBuy
10/17/2022Royal Bank of CanadaInitiated CoverageSector Perform
8/26/2022Credit Suisse GroupDowngradeNeutral ➝ Underperform
8/25/2022Jefferies Financial GroupDowngradeBuy ➝ Hold
5/23/2022CowenInitiated CoverageOutperform
1/27/2022HSBCUpgradeHold ➝ Buy
5/18/2021JPMorgan Chase & Co.UpgradeNeutral ➝ Overweight
4/12/2021JPMorgan Chase & Co.DowngradeOverweight ➝ Neutral
3/29/2021JPMorgan Chase & Co.UpgradeNeutral ➝ Overweight
2/16/2021CitigroupUpgradeNeutral ➝ Buy
1/28/2021CitigroupDowngradeBuy ➝ Neutral
7/31/2020JPMorgan Chase & Co.DowngradeNeutral ➝ Underweight
(Data available from 11/2/2019 forward)

News Sentiment Rating

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
4/6/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/6/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
6/5/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
7/5/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
8/4/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
9/3/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
10/3/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
11/2/2024

Current Sentiment

  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

  • No positive mentions tracked during this time.

Very Positive

  • No very positive mentions tracked during this time.
Allkem logo
Allkem Limited engages in the production and sale of lithium and boron in Argentina. Its flagship project is the Olaroz Lithium Facility located in Jujuy province in northern Argentina. Allkem Limited was incorporated in 2005 and is headquartered in Brisbane, Australia.
Read More

Today's Range

Now: $6.80
Low: $6.70
High: $6.80

50 Day Range

MA: $6.80
Low: $6.80
High: $6.80

52 Week Range

Now: $6.80
Low: $5.34
High: $11.66

Volume

1,900 shs

Average Volume

14,560 shs

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.68

Frequently Asked Questions

What sell-side analysts currently cover shares of Allkem?

The following Wall Street analysts have issued stock ratings on Allkem in the last twelve months:
View the latest analyst ratings for OROCF.

What is the current price target for Allkem?

0 Wall Street analysts have set twelve-month price targets for Allkem in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for Allkem in the next year.
View the latest price targets for OROCF.

What is the current consensus analyst rating for Allkem?

Allkem currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for OROCF.

What other companies compete with Allkem?

How do I contact Allkem's investor relations team?

Allkem's physical mailing address is Riparian Plaza Level 35 71 Eagle Street, Brisbane C3, QLD 4000. The company's listed phone number is (173) 064-3600 and its investor relations email address is [email protected]. The official website for Allkem is www.orocobre.com. Learn More about contacing Allkem investor relations.